Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
CPET and Exercise Prescription for Cardiac Rehabilitation
Author(s): Kaoutar Kabbadj , Nora Taiek , Wiame El Hjouji , et al Added: 1 year ago

Prevention & Chronic Conditions

Heart Failure
Exploring Exercise-induced Long QT
Author(s): William Wiradinata , Anita Dominique Subali , Muhammad Reva Aditya Added: 8 months ago

Electrophysiology & Arrhythmia

Inherited and Congenital Cardiac Conditions
HFSA 24: STEP-HFpEF: Exercise Function and Frailty Status
Author(s): Mikhail Kosiborod Added: 1 year ago
HFSA 24 - We are joined virtually by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss findings from the STEP-HFpEF trial programme in regard to the efficacy of semaglutide according to frailty status, and exercise function at baseline.Interview Questions:1. Could you remind us of the importance of STEP-HFpEF2. What was the study design and patient population?3. What… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Job title: Reader in Cardiovascular Physiology
Personal History Dr Jamie O'Driscoll is based in Canterbury, UK where he holds the position of Reader in Cardiovascular Physiology at Canterbury Christ Church University. Academic History Dr Jamie O'Driscoll, BSc (Hons), MSc (Hons), CertEd, PhD, graduated with a 1st class honours in Sport Science from Brunel University, where he went on to earn a distinction in his MSc in Health and… View more
Apical Hypertrophic Cardiomyopathy in Middle-aged Male with Chest Pain
Author(s): Kannu Bansal , Ramses Thabet Nasif Added: 1 year ago

Heart Failure
HFSA 25: Excercise Effects of Aficamten Vs Metoprolol in MAPLE-HCM
Author(s): Gregory Lewis Added: 7 months ago
HFSA 25 - Aficamten improves excercise capacity compared to metoprolol in patients with obstructive hypertrophic cardiomyopathy in a prespecified analysis of the MAPLE-HCM study.Dr Gregory Lewis joins us to discuss findings from a prespecified cardiopulmonary exercise testing analysis of the MAPLE-HCM trial, which reveals divergent effects between aficamten and metoprolol on exercise performance… View more

Heart Failure
Research Area(s) / Expertise: Job title: Professor in the Department of Health and Exercise Science and Executive Director of Healthy Exercise and Lifestyle ProgramS (HELPS)
ACC 26: ORBITA-CTO - PCI vs Placebo in Stable Angina
Author(s): Sarosh Khan , John Davies Added: 1 month ago
American College of Cardiology Congress 2026 - Dr Sarosh Khan and Dr John Davies (Essex Cardiothoracic Centre, Basildon, UK) join us to discuss results from the ORBITA-CTO trial (NCT05142215; Mid and South Essex NHS Foundation Trust), a randomised, placebo-controlled study evaluating CTO PCI versus placebo for the relief of stable angina.This double-blind, randomised, placebo-controlled pilot… View more

Intervention

Prevention & Chronic Conditions
THT 2025: GSN Ablation in HFpEF
Author(s): Marat Fudim Added: 1 year ago
THT Conference 2025 - Findings show catheter ablation of the right greater splanchnic nerve (GSN) in patients with heart failure with preserved ejection fraction (HFpEF) reduced estimated stressed blood volume in patients whether the ablation caused clinical benefits or not. This outcome indicates a confirmation of technical success that correlates with prior single-arm study findings.Dr Marat… View more

Heart Failure
Research Area(s) / Expertise: Job title: Professor of Medicine and Director of Cardiovascular Research